Ixekizumab

A Study of Ixekizumab (LY2439821) in Children With Juvenile Idiopathic Arthritis Categories of Enthesitis-related Arthritis (Including Juvenile Onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis

Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty

Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Moderate-to-Severe Plaque Psoriasis and Obesity or Overweight

Utilization of a Microdevice for Psoriasis and Atopic Dermatitis

Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Psoriatic Arthritis and Obesity or Overweight

Combination of Biologic and Anti-obesity Therapies in Psoriatic Arthritis

Ixekizumab Diabetes Intervention Trial (I-DIT)

A Study of Switching to Picankibart in Chinese Patients With Plaque Psoriasis With an Inadequate Response to Interleukin-17 Monoclonal Antibody Therapy

Dose Reduction of IL17 and IL23 Inhibitors in Psoriasis

Study to Compare Pharmacokinetics and Safety of CT-P52 and US-licensed Taltz in Healthy Subjects

A Study of Ixekizumab (LY2439821) in Participants Aged ≥18 Years With Moderate-to-Severe Plaque or Active Psoriatic Arthritis in India

Evaluating the Role of IL-17 as an Orchestrator of Peripheral-central Cross Talk in Depressive Symptoms

Targeting IL-17A for Treatment-Resistant Depression

COVID-19 VaccinE Response in Rheumatology Patients

Efficacy and Safety of Ixekizumab in Patients with Refractory Guttate Psoriasis

Ixekizumab Versus Secukizumab in Over 70-year-old Patients with Psoriasis

An Open-Label, Proof-of-Concept Study of Ixekizumab in the Treatment of Pyoderma Gangrenosum

A Study of Ixekizumab (LY2439821) in Chinese Participants With Radiographic Axial Spondyloarthritis

Study of Ixekizumab in Healthy Participants

Outcomes With Treatment and Withdraw of Ixekizumab in Patients With Plaque Psoriasis